back to overview

press

Interview with Christoph Kausch in biotechandmoney

May 02, 2018 + Jessica Di Palo
5 Min read

Dr Christoph Kausch, Managing Partner at MTIP, talks to Biotech and Money about the firm’s ambitions and its commitment to environmental, social, and governance values.

ESG compass forest

INVESTORVIEW: COMMITTING TO SOCIAL RESPONSIBILITY IN HEALTHCARE INVESTMENT

Swiss healthcare-focused venture capital firm MTIP is in the process of building a portfolio of digital health and medical technologies companies after closing its first CHF60 million fund in 2017. Dr. Christoph Kausch, Founding Partner and Chief Executive Officer at MTIP, talks to Biotech and Money about the firm’s ambitions and its commitment to environmental, social, and governance values.

Download the article here.

fun fact: bioandtechnology got rebranded to LSX Leaders. visit their website to learn more: www.lsxleaders.com

Share the Article

blog

Dealroom Report: Tooling the Physicians of the Future

European startups addressing clinical capacity bottlenecks

press

MTIP Office Featured in Swiss Office Blog

MTIP Office Featured in Swiss Office Blog

blog

Diversity, Equity, and Inclusion: The 3 Key Drivers for Success

We have talked with Caroline Noublanche, CEO of our portfolio company Apricity, about her company’s DEI efforts.

blog

Growth Capital Decisions – An Interview with our Co-Founder & Managing Partner Dr. Christoph Kausch

Growth Capital Decisions

news

Rahel Hafner Receives Certificate in ESG Investing by CFA Institute

Rahel Hafner Receives Certificate in ESG Investing

blog

What Makes a Great Founder/Investor Relationship?

Interview with the CEO and Co-Founder Kai Eberhardt of our portfolio company Oviva

news

MTIP’s HealthCare Clinic 2022

This year's HealthCare Clinic was held under the motto: "Surfing the Healthtech Waves of Change".

news

Christoph Kausch selected by Real Deals as most influential for 2022

Christoph Kausch named by Real Deals most influential for 2022

news

MTIP leads €17 million financing round in virtual fertility clinic Apricity

New MTIP investment

news

MTIP leads the €20 million growth financing round in LynxCare

Largest capital round ever in digital health in Belgium

blog

Pioneering the use of machine learning algorithms to turbo-charge drug development

Intelligencia revolutionizes drug development

blog

The psychology of decision making

What makes a good investor?

blog

Revolutionizing medical triage with artificial intelligence

Mediktor's solution for medical triage

news

MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

MTIP Fund II is closed!

blog

Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cynerio's new product Cynerio Now!

news

MTIP invests in Mediktor

New investment in Mediktor

blog

SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right

news

MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round

news

MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia

blog

Private Equity 101: Part one – Glossary

Are you new to the healthtech space?

blog

Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey

blog

Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

news blog

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations

news

MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II